IPO: NAV per share up 3.2% to 113.9p, profit £31.2m, and strong portfolio exits drive growth
NAV per share rose 3.2% to 113.9p, with profit of £31.2m and strong cash proceeds from exits. Portfolio companies raised £543m, and key assets like Pfizer's obesity programme and Oxford Nanopore drove value. Outlook remains positive with robust liquidity and a well-funded pipeline.Original document…